Table 2.
Prevalence of metabolic syndrome in Latin American countries
| Country | Year | Participants (n) | Age (years) | Diagnostic criteria | MS prevalence (%) |
|---|---|---|---|---|---|
| Chile | 2003 | 1833 | ≥17 | ATP-III | 32.0 |
| IDF | 37.0 | ||||
| Mexico | 2006 | 6021 | 20 to 69 | ATP-III | 36.8 |
| IDF | 49.8 | ||||
| Venezuela | 2001 | 3108 | ≥20 | ATP-III | 31.2 |
| Ecuador | 2004 | 352 | ≥65 | IDF | 40.0 |
| Peru | 2006 | 1878 | 20 to 80 | AHA/NHLBI | 18.8 |
| Brazil | 2001 | 1655 | 25 to 64 | ATP-III | 32.9 |
| Colombia | 2007 | 1001 | ≥18 | ATP-III | 45.6 |
| IDF | 50.4 |